Placental Growth Factor introduction webinar

We are supporting all maternity units in the North West Coast to adopt Placental Growth Factor-based tests, to reduce admissions of women at risk of pre-eclampsia. This is particularly important during the Covid-19 pandemic as it could allow women to return to community care or be monitored at home instead of being admitted to hospital for observation, if pre-eclampsia has been ruled out with a PIGF-based test. The Innovation Agency is leading an improvement collaborative which is open to staff in all North West Coast maternity units. The aim of our collaborative is to achieve PIGF-based testing in all women presenting with suspected pre-eclampsia between 20-34 weeks plus six days gestation, to help clinicians rule out pre-eclampsia (used alongside standard clinical assessment and subsequent follow up) as per NICE guidance DG23: https://www.nice.org.uk/guidance/dg23. This is a recording of the first in a series of webinars and features national PlGF champions, Obstetrics Consultants Dr Jenny Myers and Dr Manu Vatish; and test suppliers Roche and Quidel.